Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe

Author: Schiller J.   Tilden D.   Aristides M.   Lees M.   Kielhorn A.   Maniadakis N.   Bhalla S.  

Publisher: Elsevier

ISSN: 0169-5002

Source: Lung Cancer, Vol.43, Iss.1, 2004-01, pp. : 101-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content